col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

495 Results       Page 1

Elsevier: The Lancet Respiratory Medicine
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―10 Realignment of clinical research after the COVID-19 era Dennis Thomas, Vanessa M McDonald, Peter G Gibson
2 [GO] 2024―Apr―10 Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway Nhung TH Trinh, Annika M Jödicke, Martí Català, Núria Mercadé-Besora, Saeed Hayati, Angela Lupattelli, et al. (+2)
3 [GO] 2024―Feb―29 US CDC plans to relax COVID-19 isolation guidelines Bryant Furlow
4 [GO] 2024―Jan―11 The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia Martí Català, Núria Mercadé-Besora, Raivo Kolde, Nhung T H Trinh, Elena Roel, Edward Burn, et al. (+9)
5 [GO] 2024―Jan―04 Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis Francesca Gioia, Laura N Walti, Ani Orchanian-Cheff, Shahid Husain
6 [GO] 2024―Jan―04 Risk of COVID-19-associated pulmonary aspergillosis: time for a nuanced approach to antifungal prophylaxis? Martin Hoenigl, Juergen Prattes
7 [GO] 2023―Dec―12 Patterns of respiratory infections after COVID-19 The Lancet Respiratory Medicine
8 [GO] 2023―Nov―27 Vernon Lee-using one pandemic to prepare for the next Tony Kirby
9 [GO] 2023―Nov―21 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study Hui Zhang, Chaolin Huang, Xiaoying Gu, Yeming Wang, Xia Li, Min Liu, et al. (+6)
10 [GO] 2023―Nov―21 Long-term outcomes in hospitalised COVID-19 survivors and future research priorities Ash Routen, Kamlesh Khunti
11 [GO] 2023―Nov―16 Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Fengcai Zhu, Shoujie Huang, Xiaohui Liu, Qi Chen, Chunlan Zhuang, Hui Zhao, et al. (+27)
12 [GO] 2023―Nov―16 Nasally delivered SARS-CoV-2 vaccines: future promise and challenges Robert H Shaw
13 [GO] 2023―Nov―14 Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial Frances C Hall, Joseph Cheriyan, Andrew P Cope, James Galloway, Ian Wilkinson, Simon Bond, et al. (+164)
14 [GO] 2023―Nov―14 Treatment of severe COVID-19: a role for JAK and complement inhibitors? Antoine Goury, Bruno Mourvillier
15 [GO] 2023―Nov―10 COVID-19-an infectious disease in the top five causes of death in Australia Tony Kirby
16 [GO] 2023―Oct―25 Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case-control study Sara Y Tartof, Jeff M Slezak, Laura Puzniak, Vennis Hong, Timothy B Frankland, Bradley K Ackerson, et al. (+8)
17 [GO] 2023―Oct―25 To boost or not to boost: navigating post-pandemic COVID-19 vaccination Yair Goldberg, Amit Huppert
18 [GO] 2023―Oct―16 Long COVID research: an update from the PHOSP-COVID Scientific Summit Christopher E Brightling, Rachael A Evans, Amisha Singapuri, Nikki Smith, Louise V Wain, C E Brightling, et al. (+1046)
19 [GO] 2023―Sep―22 Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study J K Baillie, Nazir I Lone, S Jones, Alison Shaw, Brigid Hairsine, Claire Kurasz, et al. (+1035)
20 [GO] 2023―Sep―22 Making sense of multiorgan MRI imaging for post-acute sequelae of SARS-CoV-2 infection Matthew R Baldwin
21 [GO] 2023―Sep―15 COVID-19 boosters versus primary series: update to a living review Nana Wu, Keven Joyal-Desmarais, Ariany Marques Vieira, Comfort Sanuade, Mohit Jagwani, Laurence Paquet, et al. (+4)
22 [GO] 2023―Sep―13 Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial Gustavo H Dayan, Nadine Rouphael, Stephen R Walsh, Aiying Chen, Nicole Grunenberg, Mary Allen, et al. (+116)
23 [GO] 2023―Sep―13 Broad protection from SARS-CoV-2 variants without antigen matching Keith Chappell
24 [GO] 2023―Sep―08 Earlier start to COVID-19 autumn vaccine programmes Talha Burki
25 [GO] 2023―Aug―04 HLA-B*15:01 allele and asymptomatic SARS-CoV-2 infection Marcia Triunfol
26 [GO] 2023―Jul―19 Long COVID: confronting a growing public health crisis The Lancet Respiratory Medicine
27 [GO] 2023―Jul―17 Mitigating neurological, cognitive, and psychiatric sequelae of COVID-19-related critical illness Pratik Pandharipande, Shawniqua Williams Roberson, Fiona E Harrison, Jo Ellen Wilson, Julie A Bastarache, E Wesley Ely
28 [GO] 2023―Jul―17 Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations Matteo Parotto, Mariann Gyöngyösi, Kathryn Howe, Sheila N Myatra, Otavio Ranzani, Manu Shankar-Hari, Margaret S Herridge
29 [GO] 2023―Jul―17 Long COVID-unravelling a complex condition Carol L Hodgson, Tessa Broadley
30 [GO] 2023―Jul―12 Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial Jean-Christophe Richard, Nicolas Terzi, Hodane Yonis, Fatima Chorfa, Florent Wallet, Claire Dupuis, et al. (+40)
31 [GO] 2023―Jun―19 A negative trial for vasoactive intestinal peptide in COVID-19-associated acute hypoxaemic respiratory failure Warren L Lee, Arthur S Slutsky
32 [GO] 2023―Jun―19 Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial Samuel M Brown, Christina E Barkauskas, Birgit Grund, Shweta Sharma, Andrew N Phillips, Lindsay Leither, et al. (+506)
33 [GO] 2023―Jun―10 Inhibiting C5 in patients with severe COVID-19-the incorrect target? - Authors’ reply Djillali Annane, Sean J Pittock, Derek Dunn, Austin Kulasekararaj
34 [GO] 2023―Jun―10 Inhibiting C5 in patients with severe COVID-19-the incorrect target? Endry H T Lim, Alexander P J Vlaar, Matthijs C Brouwer, Diederik van de Beek
35 [GO] 2023―Jun―05 US CDC announces indoor air guidance for COVID-19 after 3 years Bryant Furlow
36 [GO] 2023―May―31 Nangibotide for precision immunomodulation in septic shock and COVID-19 Maniraj Neupane, Sameer S Kadri
37 [GO] 2023―May―26 WHO ends the COVID-19 public health emergency Talha Burki
38 [GO] 2023―May―19 Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation Sally J Singh, Molly M Baldwin, Enya Daynes, Rachael A Evans, Neil J Greening, R Gisli Jenkins, et al. (+9)
39 [GO] 2023―May―10 Association of SARS-CoV-2 infection and persistence with long COVID Chengliang Yang, Hedi Zhao, Estefanía Espín, Scott J Tebbutt
40 [GO] 2023―Apr―17 COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint Luca M Zaeck, Corine H GeurtsvanKessel, Rory D de Vries
41 [GO] 2023―Apr―15 Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study Callum Jackson, Iain D Stewart, Tatiana Plekhanova, Peter S Cunningham, Andrew L Hazel, Bashar Al-Sheklly, et al. (+1079)
42 [GO] 2023―Apr―15 Sleep disturbances, dyspnoea, and anxiety in long COVID W Cameron McGuire, Alex K Pearce, Atul Malhotra
43 [GO] 2023―Apr―06 Determinants of long-term outcomes in patients with COVID-19 supported with ECMO - Authors' reply Roberto Lorusso, Maria Elena De Piero, Silvia Mariani, Michele Di Mauro
44 [GO] 2023―Apr―06 Determinants of long-term outcomes in patients with COVID-19 supported with ECMO Christophe Guervilly, Marco Giani, Nicolas Nesseler, Matthieu Schmidt, Sami Hraiech
45 [GO] 2023―Mar―28 Concerns regarding a suggested long COVID paradigm Flora Cornish, Elisabeth A Stelson
46 [GO] 2023―Mar―28 Concerns regarding a suggested long COVID paradigm Fabian Schwendinger, Raphael Knaier, Arno Schmidt-Trucksäss
47 [GO] 2023―Mar―28 Concerns regarding a suggested long COVID paradigm Jenny van der Palen
48 [GO] 2023―Mar―28 Concerns regarding a suggested long COVID paradigm - Authors' reply Chloe Saunders, Søren Sperling, Elisabeth Bendstrup
49 [GO] 2023―Mar―24 Long COVID? What is that? Jules Morgan
50 [GO] 2023―Mar―21 Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial Djillali Annane, Sean J Pittock, Hrishikesh S Kulkarni, Brian W Pickering, Matt R Khoshnevis, Jason L Siegel, et al. (+8)
51 [GO] 2023―Mar―07 Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial Rong Tang, Hui Zheng, Bu-Sen Wang, Jin-Bo Gou, Xi-Ling Guo, Xiao-Qin Chen, et al. (+20)
52 [GO] 2023―Feb―22 Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials Alain Amstutz, Benjamin Speich, France Mentré, Corina Silvia Rueegg, Drifa Belhadi, Lambert Assoumou, et al. (+29)
53 [GO] 2023―Feb―11 Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022 Nana Wu, Keven Joyal-Desmarais, Paula A B Ribeiro, Ariany Marques Vieira, Jovana Stojanovic, Comfort Sanuade, et al. (+2)
54 [GO] 2023―Feb―03 Severe COVID-19 pneumonitis and timing of birth in women Clara Calvert, Sarah J Stock
55 [GO] 2023―Feb―03 Outcome predictors and patient progress following delivery in pregnant and postpartum patients with severe COVID-19 pneumonitis in intensive care units in Israel (OB-COVICU): a nationwide cohort study Elena Fatnic, Nikole Lee Blanco, Roman Cobiletchi, Esty Goldberger, Aharon Tevet, Ori Galante, et al. (+8)
56 [GO] 2023―Jan―12 Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study Matthieu Schmidt, David Hajage, Micha Landoll, Benjamin Pequignot, Elise Langouet, Matthieu Amalric, et al. (+27)
57 [GO] 2023―Jan―11 VV-ECMO in severe COVID-19: multidimensional perspectives on the use of a complex treatment Ricardo Teijeiro-Paradis, Lorenzo Del Sorbo
58 [GO] 2023―Jan―05 A new paradigm is needed to explain long COVID Chloe Saunders, Søren Sperling, Elisabeth Bendstrup
59 [GO] 2022―Dec―22 A long journey to long COVID Munyaradzi Makoni
60 [GO] 2022―Dec―14 PIONEER trial: favipiravir to treat moderate COVID-19 Sarah Shalhoub
61 [GO] 2022―Dec―14 Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care Pallav L Shah, Christopher M Orton, Beatriz Grinsztejn, Gavin C Donaldson, Brenda Crabtree Ramírez, James Tonkin, et al. (+114)
62 [GO] 2022―Dec―02 Patient collaboration in COVID-19 research: translating ideas to reality Tony Kirby
63 [GO] 2022―Nov―30 Silent Pandemic Talha Burki
64 [GO] 2022―Nov―18 Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study Matan Yechezkel, Merav Mofaz, Amichai Painsky, Tal Patalon, Sivan Gazit, Erez Shmueli, Dan Yamin
65 [GO] 2022―Nov―16 In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study Roberto Lorusso, Maria Elena De Piero, Silvia Mariani, Michele Di Mauro, Thierry Folliguet, Fabio Silvio Taccone, et al. (+511)
66 [GO] 2022―Nov―10 Tuberculosis control: getting back on track in the era of COVID-19 Talha Burki
67 [GO] 2022―Nov―04 Respiratory system mechanics, gas exchange, and outcomes in mechanically ventilated patients with COVID-19-related acute respiratory distress syndrome: a systematic review and meta-analysis Mallikarjuna Ponnapa Reddy, Ashwin Subramaniam, Clara Chua, Ryan Ruiyang Ling, Christopher Anstey, Kollengode Ramanathan, et al. (+2)
68 [GO] 2022―Nov―04 COVID-19-related acute respiratory distress syndrome: lessons learned during the pandemic Marcus J Schultz, David M van Meenen, Lieuwe D Bos
69 [GO] 2022―Oct―10 Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial John W Eikelboom, Sanjit S Jolly, Emilie P Belley-Cote, Richard P Whitlock, Sumathy Rangarajan, Lizhen Xu, et al. (+25)
70 [GO] 2022―Oct―10 Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial John W Eikelboom, Sanjit S Jolly, Emilie P Belley-Cote, Richard P Whitlock, Sumathy Rangarajan, Lizhen Xu, et al. (+23)
71 [GO] 2022―Oct―10 Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial Nicola K Love, Derren R Ready, Charlie Turner, Neville Q Verlander, Clare E French, Alex F Martin, et al. (+8)
72 [GO] 2022―Oct―10 Prognostic factors associated with mortality among patients receiving venovenous extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis Alexandre Tran, Shannon M Fernando, Bram Rochwerg, Ryan P Barbaro, Carol L Hodgson, Laveena Munshi, et al. (+10)
73 [GO] 2022―Oct―10 COVID-19: ACT trials for colchicine and antithrombotic therapies Stefano Barco, Karen Schreiber
74 [GO] 2022―Oct―10 Respiratory support before venovenous ECMO for COVID-19: what is the price? Marco Giani, Emanuele Rezoagli
75 [GO] 2022―Oct―10 SARS-CoV-2: can isolation be limited to those who are truly infectious? Elen Vink, Antonia Ho
76 [GO] 2022―Oct―07 The elusive goal of COVID-19 vaccine immunity Laith J Abu-Raddad, Hiam Chemaitelly
77 [GO] 2022―Oct―07 Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study Sarah J Stock, Emily Moore, Clara Calvert, Jade Carruthers, Cheryl Denny, Jack Donaghy, et al. (+16)
78 [GO] 2022―Oct―07 Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control study Sara Y Tartof, Jeff M Slezak, Laura Puzniak, Vennis Hong, Timothy B Frankland, Fagen Xie, et al. (+4)
79 [GO] 2022―Sep―30 The long shadow of COVID-19 in Africa Munyaradzi Makoni
80 [GO] 2022―Sep―13 Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients? Andre C Kalil, Michael Proschan
81 [GO] 2022―Sep―07 Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial Alexander P J Vlaar, Martin Witzenrath, Pieter van Paassen, Leo M A Heunks, Bruno Mourvillier, Sanne de Bruin, et al. (+103)
82 [GO] 2022―Sep―05 Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial Holly R Keir, Merete B Long, Hani Abo-Leyah, Yan Hui Giam, Thenmalar Vadiveloo, Thomas Pembridge, et al. (+189)
83 [GO] 2022―Sep―05 Is neutrophilic inflammation treatable in COVID-19? Catharina Conrad, Mark R Looney
84 [GO] 2022―Aug―31 Interrupting methotrexate to improve immunity after COVID-19 booster vaccination: is it really worth it? Anselm Jorda, Markus Zeitlinger
85 [GO] 2022―Aug―26 Wearable technology and COVID-19 Talha Burki
86 [GO] 2022―Aug―24 Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study Simon Feys, Samuel M Gonçalves, Mona Khan, Sumin Choi, Bram Boeckx, Denis Chatelain, et al. (+28)
87 [GO] 2022―Aug―18 Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study Seran Hakki, Jie Zhou, Jakob Jonnerby, Anika Singanayagam, Jack L Barnett, Kieran J Madon, et al. (+40)
88 [GO] 2022―Aug―16 Smoking, nicotine, and COVID-19 Jonathan Grigg
89 [GO] 2022―Aug―16 Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research Neal L Benowitz, Maciej L Goniewicz, Bonnie Halpern-Felsher, Suchitra Krishnan-Sarin, Pamela M Ling, Richard J O'Connor, et al. (+3)
90 [GO] 2022―Jul―08 Monoclonals for patients hospitalised with COVID-19 Jason M Pogue, Erin K McCreary
91 [GO] 2022―Jul―08 Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
92 [GO] 2022―Jul―04 COVID-19 pandemic disturbs respiratory virus dynamics The Lancet Respiratory Medicine
93 [GO] 2022―Jun―27 Improving COVID-19 vaccine immunogenicity by interrupting methotrexate treatment Jeffrey A Sparks, Sara K Tedeschi
94 [GO] 2022―Jun―27 Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial Abhishek Abhishek, Rosemary J Boyton, Nicholas Peckham, Áine McKnight, Laura C Coates, James Bluett, et al. (+62)
95 [GO] 2022―Jun―15 Negative impact from school closures on children and parents in Vietnam during COVID-19 Ngoc Phuong Hong Tao, Abdelrahman M Makram, Phan Nguyen Quoc Khanh, Nguyen Thanh An, Adnan Safi, Nguyen Tien Huy
96 [GO] 2022―Jun―15 The COVID-19 continuum of illness Margaret S Herridge, Élie Azoulay
97 [GO] 2022―Jun―13 Early-phase clinical trials in a pandemic: learning from the response to COVID-19 Alex Horsley, Chris Brightling, Jane Davies, Ratko Djukanovic, Liam G Heaney, Tracy Hussell, et al. (+5)
98 [GO] 2022―Jun―13 Use of pragmatic and explanatory trial designs in acute care research: lessons from COVID-19 Jonathan D Casey, Laura M Beskow, Jeremy Brown, Samuel M Brown, Étienne Gayat, Michelle Ng Gong, et al. (+13)
99 [GO] 2022―Jun―11 A glimpse into long COVID and symptoms Chengliang Yang, Hedi Zhao, Scott J Tebbutt
100 [GO] 2022―Jun―11 A glimpse into long COVID and symptoms - Authors' reply Lixue Huang, Xiaoying Gu, Hui Zhang, Bin Cao
101 [GO] 2022―Jun―10 Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial Rolando Ochoa-Azze, Arturo Chang-Monteagudo, Yanet Climent-Ruiz, Consuelo Macías-Abraham, Carmen Valenzuela-Silva, María de los Ángeles García-García, et al. (+24)
102 [GO] 2022―Jun―09 Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial Robert H Shaw, Xinxue Liu, Arabella S V Stuart, Melanie Greenland, Parvinder K Aley, Nick J Andrews, et al. (+78)
103 [GO] 2022―Jun―07 Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial Hugh Montgomery, F D Richard Hobbs, Francisco Padilla, Douglas Arbetter, Alison Templeton, Seth Seegobin, et al. (+272)
104 [GO] 2022―Jun―07 Early treatment to prevent progression of SARS-CoV-2 infection Myron S Cohen
105 [GO] 2022―May―31 Rethinking the efficacy of awake prone positioning in COVID-19-related acute hypoxaemic respiratory failure Qinyuan Li, Qi Zhou, Kehu Yang, Zhengxiu Luo, Yaolong Chen
106 [GO] 2022―May―31 Rethinking the efficacy of awake prone positioning in COVID-19-related acute hypoxaemic respiratory failure - Authors' reply Jian Luo, Ivan Pavlov, Elsa Tavernier, John G Laffey, Claude Guerin, David Vines, et al. (+8)
107 [GO] 2022―May―26 Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials Fengcai Zhu, Chunlan Zhuang, Kai Chu, Liang Zhang, Hui Zhao, Shoujie Huang, et al. (+26)
108 [GO] 2022―May―24 The future of Paxlovid for COVID-19 Talha Burki
109 [GO] 2022―May―24 The quest for more COVID-19 vaccinations in Africa Munyaradzi Makoni
110 [GO] 2022―May―23 Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial Cameron R Wolfe, Kay M Tomashek, Thomas F Patterson, Carlos A Gomez, Vincent C Marconi, Mamta K Jain, et al. (+230)
111 [GO] 2022―May―23 Future threats from coronaviruses Priya Venkatesan
112 [GO] 2022―May―20 Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial Jing-Xin Li, Shi-Po Wu, Xi-Ling Guo, Rong Tang, Bao-Ying Huang, Xiao-Qin Chen, et al. (+38)
113 [GO] 2022―May―11 Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study Lixue Huang, Xia Li, Xiaoying Gu, Hui Zhang, LiLi Ren, Li Guo, et al. (+10)
114 [GO] 2022―May―04 Long COVID: aiming for a consensus Daniel Munblit, Margaret E O'Hara, Athena Akrami, Elisa Perego, Piero Olliaro, Dale M Needham
115 [GO] 2022―Apr―28 How repeated influenza vaccination effects might apply to COVID-19 vaccines Mark G Thompson, Benjamin J Cowling
116 [GO] 2022―Apr―27 Treating COVID-19-related breathlessness with novel interventions Enya Daynes
117 [GO] 2022―Apr―27 An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial Keir E J Philip, Harriet Owles, Stephanie McVey, Tanja Pagnuco, Katie Bruce, Harry Brunjes, et al. (+11)
118 [GO] 2022―Apr―27 How to survive a pandemic Talha Burki
119 [GO] 2022―Apr―23 Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study R A Evans, O C Leavy, M Richardson, O Elneima, H J C McCauley, A Shikotra, et al. (+1000)
120 [GO] 2022―Apr―23 Long COVID: systemic inflammation and obesity as therapeutic targets Lidiane L Florencio, César Fernández-de-las-Peñas
121 [GO] 2022―Apr―11 Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis Ryan Ruiyang Ling, Kollengode Ramanathan, Felicia Liying Tan, Bee Choo Tai, Jyoti Somani, Dale Fisher, Graeme MacLaren
122 [GO] 2022―Apr―11 Myopericarditis after COVID-19 vaccination: unexpected but not unprecedented Margaret Ryan, Jay Montgomery
123 [GO] 2022―Apr―07 Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis Jonathan R Baker, Mahdi Mahdi, Dan V Nicolau, Sanjay Ramakrishnan, Peter J Barnes, Jodie L Simpson, et al. (+4)
124 [GO] 2022―Apr―07 Inhaled corticosteroids: not just for asthma, but for COVID-19? Felicity Liew, Peter J M Openshaw
125 [GO] 2022―Mar―24 The crucial need for tuberculosis translational research in the time of COVID-19 Fei Kean Loh, Pei Min Thong, Catherine W M Ong
126 [GO] 2022―Mar―24 Supporting families with tuberculosis during COVID-19 in Khayelithsa, South Africa Ivy Apolisi, Nandipha Mema, Nolitha Tyeku, Busisiwe Beko, Boniwe Memani, Johnny Daniels, et al. (+12)
127 [GO] 2022―Mar―24 Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress? Molebogeng X Rangaka, Yohhei Hamada, Ibrahim Abubakar
128 [GO] 2022―Mar―24 The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions Keertan Dheda, Tahlia Perumal, Harry Moultrie, Rubeshan Perumal, Aliasgar Esmail, Alex J Scott, et al. (+15)
129 [GO] 2022―Mar―16 Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic review and meta-analysis Jie Li, Jian Luo, Ivan Pavlov, Yonatan Perez, Wei Tan, Oriol Roca, et al. (+47)
130 [GO] 2022―Mar―16 Effects of SARS-CoV-2 on prenatal lung growth assessed by fetal MRI Sophia Stoecklein, Vanessa Koliogiannis, Tobias Prester, Thomas Kolben, Magdalena Jegen, Christoph Hübener, et al. (+12)
131 [GO] 2022―Mar―16 The pandemic and the great awakening in the management of acute hypoxaemic respiratory failure Kiran Shekar, Ryan Ruiyang Ling
132 [GO] 2022―Mar―03 COVID-19 vaccination in young children Talha Khan Burki
133 [GO] 2022―Feb―25 Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study Paul M McKeigue, David A McAllister, Sharon J Hutchinson, Chris Robertson, Diane Stockton, Helen M Colhoun
134 [GO] 2022―Feb―25 Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study Bill J Wright, Samuel Tideman, George A Diaz, Thomas French, Guilford T Parsons, Ari Robicsek
135 [GO] 2022―Feb―17 Long-term clinical outcomes of COVID-19 patients treated with imatinib Erik Duijvelaar, Job R Schippers, Patrick J Smeele, Michiel Alexander de Raaf, Arthur L E M Vanhove, Siebe G Blok, et al. (+5)
136 [GO] 2022―Feb―17 A pandemic is no private matter: the COVID-19 vaccine mandate in Austria Christiane Druml, Herwig Czech
137 [GO] 2022―Feb―10 Future pandemics: failing to prepare means preparing to fail The Lancet Respiratory Medicine
138 [GO] 2022―Feb―09 Convalescent plasma in outpatients with COVID-19 Daniele Focosi, Arturo Casadevall
139 [GO] 2022―Feb―09 High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial Andrea Alemany, Pere Millat-Martinez, Marc Corbacho-Monné, Pierre Malchair, Dan Ouchi, Anna Ruiz-Comellas, et al. (+102)
140 [GO] 2022―Feb―03 Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis Justin de Brabander, Leonoor S Boers, Robert F J Kullberg, Jan W Duitman, Lieuwe D J Bos
141 [GO] 2022―Feb―03 Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis - Authors' reply Jean-Pierre Gangneux, Jeff Morcet, Bruno Laviolle, Eric Dannaoui, Jean-François Timsit, Stéphane Ruckly, et al. (+2)
142 [GO] 2022―Feb―03 Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial E Wesley Ely, Athimalaipet V Ramanan, Cynthia E Kartman, Stephanie de Bono, Ran Liao, Maria Lucia B Piruzeli, et al. (+21)
143 [GO] 2022―Feb―03 Baricitinib for patients with severe COVID-19-time to change the standard of care? Alexander Supady, Robert Zeiser
144 [GO] 2022―Feb―02 Why the application of IVIG might be beneficial in patients with COVID-19 Detlef Kindgen-Milles, Torsten Feldt, Bjoern Erik Ole Jensen, Thomas Dimski, Timo Brandenburger
145 [GO] 2022―Feb―02 Why the application of IVIG might be beneficial in patients with COVID-19 - Authors' reply Aurélien Mazeraud, Michel Wolff, Bruno Lucas, Tarek Sharshar
146 [GO] 2022―Feb―02 Awake prone positioning for COVID-19 acute respiratory failure: imaging and histological background Sara Piciucchi, Claudia Ravaglia, Antonio Vizzuso, Emanuela Giampalma, Venerino Poletti
147 [GO] 2022―Feb―01 Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study Ruvim Izikson, Daniel Brune, Jean-Sébastien Bolduc, Pierre Bourron, Marion Fournier, Tamala Mallett Moore, et al. (+6)
148 [GO] 2022―Jan―24 Tracing and vaccinating: how to REACT to COVID-19 pandemic Riccardo Castagnoli, Gian Luigi Marseglia
149 [GO] 2022―Jan―24 SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys Marc Chadeau-Hyam, Haowei Wang, Oliver Eales, David Haw, Barbara Bodinier, Matthew Whitaker, et al. (+16)
150 [GO] 2022―Jan―20 Do vaccines protect from long COVID? Priya Venkatesan
151 [GO] 2022―Jan―14 Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study Ting Shi, Jiafeng Pan, Eleftheria Vasileiou, Chris Robertson, Aziz Sheikh
152 [GO] 2022―Jan―14 The role of antiviral treatment in the COVID-19 pandemic Talha Khan Burki
153 [GO] 2022―Jan―13 Why has the incidence of tuberculosis not reduced in London during the COVID-19 pandemic? Dan Lewer, Ranya Mulchandani, Anita Roche, Catherine Cosgrove, Charlotte Anderson
154 [GO] 2022―Jan―11 Fourth dose of COVID-19 vaccines in Israel Talha Khan Burki
155 [GO] 2021―Dec―17 Omicron variant and booster COVID-19 vaccines Talha Khan Burki
156 [GO] 2021―Dec―16 Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial Benjamin A Fisher, Tonny Veenith, Daniel Slade, Charlotte Gaskell, Matthew Rowland, Tony Whitehouse, et al. (+52)
157 [GO] 2021―Dec―11 Tolerability and impact of SARS-CoV-2 vaccination in elite athletes James H Hull, Moses Wootten, Craig Ranson
158 [GO] 2021―Dec―09 Changes in rates of prescriptions for inhaled corticosteroids during the COVID-19 pandemic Joanne Crook, John Weinman, Atul Gupta
159 [GO] 2021―Dec―03 Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19 Luke Milross, Joaquim Majo, Nigel Cooper, Paul M Kaye, Omer Bayraktar, Andrew Filby, Andrew J Fisher
160 [GO] 2021―Dec―02 Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial Zelalem Temesgen, Charles D Burger, Jason Baker, Christopher Polk, Claudia R Libertin, Colleen F Kelley, et al. (+118)
161 [GO] 2021―Dec―02 Stimulating severe COVID-19: the potential role of GM-CSF antagonism Helen L Leavis, Frank L van de Veerdonk, Srinivas Murthy
162 [GO] 2021―Dec―01 Prone positioning might reduce the need for intubation in people with severe COVID-19 W Cameron McGuire, Alex K Pearce, Atul Malhotra
163 [GO] 2021―Dec―01 Prone positioning might reduce the need for intubation in people with severe COVID-19 - Authors' reply Miguel Ibarra-Estrada, Jie Li, John G Laffey, Ivan Pavlov, Oriol Roca, Yonatan Perez, et al. (+4)
164 [GO] 2021―Dec―01 Risk of COVID-19 hospital admission among children aged 5-17 years with asthma in Scotland: a national incident cohort study Ting Shi, Jiafeng Pan, Srinivasa Vittal Katikireddi, Colin McCowan, Steven Kerr, Utkarsh Agrawal, et al. (+5)
165 [GO] 2021―Dec―01 Risk of COVID-19 hospital admission among children with asthma Rachel Harwood, Ian P Sinha
166 [GO] 2021―Nov―26 Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study Jean-Pierre Gangneux, Eric Dannaoui, Arnaud Fekkar, Charles-Edouard Luyt, Françoise Botterel, Nicolas De Prost, et al. (+64)
167 [GO] 2021―Nov―26 Managing secondary fungal infections in severe COVID-19: how to move forward? Paul E Verweij, Frank L van de Veerdonk
168 [GO] 2021―Nov―25 Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia Jean-Louis Vincent, Marcel Levi, Beverley J Hunt
169 [GO] 2021―Nov―17 Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines Daniel M Altmann, Rosemary J Boyton
170 [GO] 2021―Nov―17 Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial Seth Toback, Eva Galiza, Catherine Cosgrove, James Galloway, Anna L Goodman, Pauline A Swift, et al. (+306)
171 [GO] 2021―Nov―11 Intravenous immunoglobulin therapy for COVID-19 ARDS Erin M Wilfong, Michael A Matthay
172 [GO] 2021―Nov―11 Undetected COVID-19 cases in Africa Talha Khan Burki
173 [GO] 2021―Nov―11 Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial Aurélien Mazeraud, Matthieu Jamme, Rossella Letizia Mancusi, Claire Latroche, Bruno Megarbane, Shidasp Siami, et al. (+32)
174 [GO] 2021―Nov―09 Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research Sampath Weerakkody, Pietro Arina, James Glenister, Sam Cotterell, Giacomo Boscaini-Gilroy, Mervyn Singer, Hugh E Montgomery
175 [GO] 2021―Nov―03 Global tuberculosis progress reversed by COVID-19 pandemic Tony Kirby
176 [GO] 2021―Oct―29 The course of action for effective anti-cytokine treatment in COVID-19 Giulio Cavalli, Lorenzo Dagna
177 [GO] 2021―Oct―29 Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial Jozefien Declercq, Karel F A Van Damme, Elisabeth De Leeuw, Bastiaan Maes, Cedric Bosteels, Simon J Tavernier, et al. (+37)
178 [GO] 2021―Oct―22 Colchicine treatment in COVID-19: the remaining unsolved question Adriana Rojas-Villarraga, Rafael Parra-Medina, Arley Gómez-López
179 [GO] 2021―Oct―22 Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care Ann M Parker, Emily Brigham, Bronwen Connolly, Joanne McPeake, Anna V Agranovich, Michael T Kenes, et al. (+8)
180 [GO] 2021―Oct―22 Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity? Gregory Milne, Thomas Hames, Chris Scotton, Nick Gent, Alexander Johnsen, Roy M Anderson, Tom Ward
181 [GO] 2021―Oct―22 Waning immunity to SARS-CoV-2: implications for vaccine booster strategies Daniel M Altmann, Rosemary J Boyton
182 [GO] 2021―Oct―19 Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
183 [GO] 2021―Oct―19 Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial Andre C Kalil, Aneesh K Mehta, Thomas F Patterson, Nathaniel Erdmann, Carlos A Gomez, Mamta K Jain, et al. (+206)
184 [GO] 2021―Oct―19 Subcutaneous interferon beta-1a in COVID-19: raking the ashes of an intervention trial Tom Wilkinson
185 [GO] 2021―Oct―14 Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan Szu-Min Hsieh, Ming-Che Liu, Yen-Hsu Chen, Wen-Sen Lee, Shinn-Jang Hwang, Shu-Hsing Cheng, et al. (+14)
186 [GO] 2021―Oct―13 Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts Lieuwe D J Bos, Michael Sjoding, Pratik Sinha, Sivasubramanium V Bhavani, Patrick G Lyons, Alice F Bewley, et al. (+98)
187 [GO] 2021―Oct―13 COVID-19-related ARDS: one disease, two trajectories, and several unanswered questions Jean-Baptiste Lascarrou
188 [GO] 2021―Oct―09 Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study Rachael A Evans, Hamish McAuley, Ewen M Harrison, Aarti Shikotra, Amisha Singapuri, Marco Sereno, et al. (+771)
189 [GO] 2021―Oct―09 Surviving COVID-19: a familiar road to recovery? Linda Denehy, Zudin Puthucheary
190 [GO] 2021―Sep―30 COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study Utkarsh Agrawal, Srinivasa Vittal Katikireddi, Colin McCowan, Rachel H Mulholland, Amaya Azcoaga-Lorenzo, Sarah Amele, et al. (+25)
191 [GO] 2021―Sep―29 Severe breakthrough COVID-19 infections in Scotland-implications for immunisation programmes Eyal Leshem, Kristin Nelson, Benjamin Alan Lopman
192 [GO] 2021―Sep―29 The race between vaccination and evolution of COVID-19 variants Talha Khan Burki
193 [GO] 2021―Sep―09 Azithromycin for mild-to-moderate COVID-19 - Authors' reply Timothy S C Hinks
194 [GO] 2021―Sep―09 Azithromycin for mild-to-moderate COVID-19 Jigar Patel, Ivan Berezowski, Ahmed Abdelmonem, Dania Taylor, Ali Pourmand
195 [GO] 2021―Sep―07 Pathological disease in the lung periphery after acute COVID-19 Salman Siddiqui, Christopher E Brightling
196 [GO] 2021―Sep―01 Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial Vincent C Marconi, Athimalaipet V Ramanan, Stephanie de Bono, Cynthia E Kartman, Venkatesh Krishnan, Ran Liao, et al. (+101)
197 [GO] 2021―Sep―01 Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial Andre C Kalil, Justin Stebbing
198 [GO] 2021―Aug―20 Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial Stephan Ehrmann, Jie Li, Miguel Ibarra-Estrada, Yonatan Perez, Ivan Pavlov, Bairbre McNicholas, et al. (+176)
199 [GO] 2021―Aug―20 Awake prone positioning in COVID-19: is tummy time ready for prime time? Jason Weatherald, John Norrie, Ken Kuljit S Parhar
200 [GO] 2021―Aug―17 COVID-19 vaccines: addressing hesitancy in young people with allergies Elissa M Abrams, Marcus Shaker, Ian Sinha, Matthew Greenhawt
201 [GO] 2021―Aug―17 The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease Davies Adeloye, Omer Elneima, Luke Daines, Krisnah Poinasamy, Jennifer K Quint, Samantha Walker, et al. (+11)
202 [GO] 2021―Aug―17 Charting a course for the management of long COVID Richard Beasley, Nethmi Kearns, Tom Hills
203 [GO] 2021―Aug―16 COVID-19, smoking, and cancer: a dangerous liaison The Lancet Respiratory Medicine
204 [GO] 2021―Aug―13 Heterologous ChAdOx1-nCoV19-BNT162b2 vaccination provides superior immunogenicity against COVID-19 Christopher D Richardson
205 [GO] 2021―Aug―13 Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study David Hillus, Tatjana Schwarz, Pinkus Tober-Lau, Kanika Vanshylla, Hana Hastor, Charlotte Thibeault, et al. (+65)
206 [GO] 2021―Aug―06 Circulation of influenza, RSV, and SARS-CoV-2: an uncertain season ahead Talha Khan Burki
207 [GO] 2021―Jul―29 Tobacco industry capitalises on the COVID-19 pandemic Talha Khan Burki
208 [GO] 2021―Jul―28 PRINCIPLE: a community-based COVID-19 platform trial John Macleod, John Norrie
209 [GO] 2021―Jul―27 Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial Christopher C Butler, Ly-Mee Yu, Jienchi Dorward, Oghenekome Gbinigie, Gail Hayward, Benjamin R Saville, et al. (+15)
210 [GO] 2021―Jul―17 Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease John A Mackintosh, Marc Lipman, David M Lowe, Elisabetta A Renzoni
211 [GO] 2021―Jul―15 Recovery after prolonged ICU treatment in patients with COVID-19 Matteo Parotto, Sheila Nainan Myatra, Daniel Munblit, Alyaa Elhazmi, Otavio T Ranzani, Margaret S Herridge
212 [GO] 2021―Jul―15 COVID-19 hospital admissions: Brazil's first and second waves compared Leonardo SL Bastos, Otavio T Ranzani, Thiago Moreno L Souza, Silvio Hamacher, Fernando A Bozza
213 [GO] 2021―Jul―12 Lifting of COVID-19 restrictions in the UK and the Delta variant Talha Khan Burki
214 [GO] 2021―Jul―09 Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial Timothy S C Hinks, Lucy Cureton, Ruth Knight, Ariel Wang, Jennifer L Cane, Vicki S Barber, et al. (+16)
215 [GO] 2021―Jul―09 Ongoing asthma management in children during the COVID-19 pandemic: to step down or not to step down? Elissa Michele Abrams, Stanley Szefler
216 [GO] 2021―Jul―09 Azithromycin: can its benefit be ruled out in mild COVID-19? Alejandro Rodríguez-Molinero
217 [GO] 2021―Jul―06 Cytokine adsorption and ECMO in patients with COVID-19 Pasquale Nardelli, Marina Pieri, Evgeny Fominskiy, Anna Mara Scandroglio
218 [GO] 2021―Jul―06 Cytokine adsorption and ECMO in patients with COVID-19 Andrey Rybalko, Alexander V Voronin, Nikolai A Karpun
219 [GO] 2021―Jul―06 Cytokine adsorption and ECMO in patients with COVID-19 - Author's reply Alexander Supady
220 [GO] 2021―Jul―02 Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study Elisa Estenssoro, Cecilia I Loudet, Fernando G Ríos, Vanina S Kanoore Edul, Gustavo Plotnikow, Macarena Andrian, et al. (+144)
221 [GO] 2021―Jul―02 BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers Yaniv Lustig, Einav Sapir, Gili Regev-Yochay, Carmit Cohen, Ronen Fluss, Liraz Olmer, et al. (+10)
222 [GO] 2021―Jul―02 Lung transplantation for COVID-19-associated ARDS Philipp M Lepper, Frank Langer, Heinrike Wilkens, Hans-Joachim Schäfers, Robert Bals
223 [GO] 2021―Jul―02 Lung transplantation for COVID-19-associated ARDS Jonathan Messika, Matthieu Schmidt, Alexy Tran-Dinh, Pierre Mordant
224 [GO] 2021―Jul―02 Lung transplantation for COVID-19-associated ARDS - Authors' reply Ankit Bharat, Konrad Hoetzenecker, Tiago N Machuca
225 [GO] 2021―Jul―02 Battling COVID-19-related mortality: from a fight for ventilators to a cry for oxygen Marcus J Schultz, Ary Serpa Neto, Frederique Paulus
226 [GO] 2021―Jul―01 COVID-19 and the mental health of children with respiratory illness Ian P Sinha, Ruth Murphy, Holly Biffin, Lucy Gait, Elissa M Abrams, Alice R Lee, et al. (+6)
227 [GO] 2021―Jun―30 Implications of the second wave of COVID-19 in India Purva Asrani, Mathew Suji Eapen, Md Imtaiyaz Hassan, Sukhwinder Singh Sohal
228 [GO] 2021―Jun―18 Association between sex and SARS-CoV-2 infection and hospitalisation as a result of COVID-19 Yochai Adir, Marc Humbert, Walid Saliba
229 [GO] 2021―Jun―18 COVID-19 vaccination in patients with α1-antitrypsin deficiency Chengliang Yang, Hedi Zhao
230 [GO] 2021―Jun―18 Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial Jurjan Aman, Erik Duijvelaar, Liza Botros, Azar Kianzad, Job R Schippers, Patrick J Smeele, et al. (+59)
231 [GO] 2021―Jun―18 Imatinib in COVID-19: hope and caution David Bernal-Bello, Alejandro Morales-Ortega, Ana Isabel Farfán-Sedano, Jaime García de Tena, Juan Víctor San Martín-López
232 [GO] 2021―Jun―16 Extracorporeal membrane oxygenation for COVID-19 during first and second waves Lars Mikael Broman, Staffan Eksborg, Valeria Lo Coco, Maria Elena De Piero, Jan Belohlavek, Roberto Lorusso
233 [GO] 2021―Jun―14 SARS-CoV-2 antigen testing: weighing the false positives against the costs of failing to control transmission Elizabeth Fearon, Iain E Buchan, Rajenki Das, Emma L Davis, Martyn Fyles, Ian Hall, et al. (+9)
234 [GO] 2021―Jun―11 Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial Axel Bauer, Michael Schreinlechner, Nikolay Sappler, Theresa Dolejsi, Herbert Tilg, Benedikt A Aulinger, et al. (+108)
235 [GO] 2021―Jun―11 RAS inhibition and COVID-19: more questions than answers? Mathieu Kerneis, Gilles Montalescot
236 [GO] 2021―Jun―09 Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19 Laurens J Ceulemans, Mona Khan, Seung-Jun Yoo, Bolek Zapiec, Laura Van Gerven, Jan Van Slambrouck, et al. (+7)
237 [GO] 2021―Jun―03 Repurposing drugs for treatment of COVID-19 Priya Venkatesan
238 [GO] 2021―Jun―03 Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? Akshay Raut, Nguyen Tien Huy
239 [GO] 2021―Jun―02 COVID-19 pathophysiology: looking beyond acute disease The Lancet Respiratory Medicine
240 [GO] 2021―May―27 Exploiting an early immunological window of opportunity in COVID-19 Clark D Russell
241 [GO] 2021―May―27 Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial Jean-Claude Tardif, Nadia Boꯚllaoui, Philippe L L'Allier, Daniel Gaudet, Binita Shah, Michael H Pillinger, et al. (+38)
242 [GO] 2021―May―26 COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion Frank L van de Veerdonk, Roger J M Brüggemann, Shoko Vos, Gert De Hertogh, Joost Wauters, Monique H E Reijers, et al. (+3)
243 [GO] 2021―May―21 Passive tobacco smoke in children and young people during the COVID-19 pandemic Mira Osinibi, Atul Gupta, Katharine Harman, Cara J Bossley
244 [GO] 2021―May―21 Ensuring fair distribution of COVID-19 vaccines: is an intellectual waiver the answer? Talha Khan Burki
245 [GO] 2021―May―18 Vascular mechanisms and manifestations of COVID-19 Marcel Levi, Michiel Coppens
246 [GO] 2021―May―18 Immunotherapy in COVID-19: why, who, and when? Pratik Sinha, Carolyn S Calfee
247 [GO] 2021―May―14 A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19 Dennis McGonagle, Charlie Bridgewood, James F M Meaney
248 [GO] 2021―May―14 Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial Alexander Supady, Enya Weber, Marina Rieder, Achim Lother, Tim Niklaus, Timm Zahn, et al. (+17)
249 [GO] 2021―May―14 Cytokine adsorption during ECMO for COVID-19-related ARDS Kiran Shekar, Daniel F McAuley, Daniel Brodie
250 [GO] 2021―May―14 Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK Annemarie B Docherty, Rachel H Mulholland, Nazir I Lone, Christopher P Cheyne, Daniela De Angelis, Karla Diaz-Ordaz, et al. (+374)
251 [GO] 2021―May―12 Inhaled budesonide for early treatment of COVID-19 Jae Chol Choi, Won-Young Kim
252 [GO] 2021―May―12 Inhaled budesonide for early treatment of COVID-19 Rafael San-Juan, Mario Fernández-Ruiz, Francisco López-Medrano, José María Aguado
253 [GO] 2021―May―12 Inhaled budesonide for early treatment of COVID-19 Markus Zeitlinger, Marco Idzko
254 [GO] 2021―May―12 Inhaled budesonide for early treatment of COVID-19 - Authors' reply Sanjay Ramakrishnan, Mona Bafadhel
255 [GO] 2021―May―07 The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity Marcin F Osuchowski, Martin S Winkler, Tomasz Skirecki, Sara Cajander, Manu Shankar-Hari, Gunnar Lachmann, et al. (+28)
256 [GO] 2021―May―07 Aerosol generating procedures: are they of relevance for transmission of SARS-CoV-2? Fergus Hamilton, David Arnold, Bryan R Bzdek, James Dodd, Jonathan Reid, Nick Maskell, et al. (+18)
257 [GO] 2021―May―05 An integrated understanding of long-term sequelae after acute COVID-19 Piero L Olliaro
258 [GO] 2021―May―05 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study Xiaojun Wu, Xiaofan Liu, Yilu Zhou, Hongying Yu, Ruiyun Li, Qingyuan Zhan, et al. (+10)
259 [GO] 2021―May―05 Viable virus shedding during SARS-CoV-2 reinfection Andrew G Letizia, Darci R Smith, Yongchao Ge, Irene Ramos, Rachel S G Sealfon, Carl Goforth, et al. (+22)
260 [GO] 2021―Apr―28 From lockdown to vaccines: challenges and response in Nepal during the COVID-19 pandemic Sajog Kansakar, Shyam Prakash Dumre, Akshay Raut, Nguyen Tien Huy
261 [GO] 2021―Apr―27 Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context Federico Angriman, Bruno L Ferreyro, Lisa Burry, Eddy Fan, Niall D Ferguson, Shahid Husain, et al. (+7)
262 [GO] 2021―Apr―20 COVID-19 and ECMO: a call for close cooperation and more investigation Roberto Lorusso, Thomas Mueller
263 [GO] 2021―Apr―20 Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study Guillaume Lebreton, Matthieu Schmidt, Maharajah Ponnaiah, Thierry Folliguet, Marylou Para, Julien Guihaire, et al. (+174)
264 [GO] 2021―Apr―20 Saliva as a gold-standard sample for SARS-CoV-2 detection Steph H Tan, Orchid Allicock, Mari Armstrong-Hough, Anne L Wyllie
265 [GO] 2021―Apr―19 Non-invasive respiratory support strategies in COVID-19 Ellen Gorman, Bronwen Connolly, Keith Couper, Gavin D Perkins, Daniel F McAuley
266 [GO] 2021―Apr―16 SARS-CoV-2 reinfection in a closed setting: lessons for the community María Velasco, Carlos Guijarro
267 [GO] 2021―Apr―16 SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study Andrew G Letizia, Yongchao Ge, Sindhu Vangeti, Carl Goforth, Dawn L Weir, Natalia A Kuzmina, et al. (+29)
268 [GO] 2021―Apr―14 Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses Woo-Jung Song, Christopher K M Hui, James H Hull, Surinder S Birring, Lorcan McGarvey, Stuart B Mazzone, Kian Fan Chung
269 [GO] 2021―Apr―09 Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19 Alvar Agusti, Ferran Torres, Rosa Faner
270 [GO] 2021―Apr―09 COVID-19 severity and obesity: are MAIT cells a factor? Cormac McCarthy, Cliona P O'Donnell, Neil E Wrigley Kelly, Donal O'Shea, Andrew E Hogan
271 [GO] 2021―Apr―09 Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial Sanjay Ramakrishnan, Dan V Nicolau, Beverly Langford, Mahdi Mahdi, Helen Jeffers, Christine Mwasuku, et al. (+18)
272 [GO] 2021―Apr―09 Pandemic fans the flames of smoking and health inequity The Lancet Respiratory Medicine
273 [GO] 2021―Apr―02 Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study Paul Aveyard, Min Gao, Nicola Lindson, Jamie Hartmann-Boyce, Peter Watkinson, Duncan Young, et al. (+7)
274 [GO] 2021―Apr―01 Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries Ankit Bharat, Tiago N Machuca, Melissa Querrey, Chitaru Kurihara, Rafael Garza-Castillon, Samuel Kim, et al. (+19)
275 [GO] 2021―Mar―31 Should we ration extracorporeal membrane oxygenation during the COVID-19 pandemic? Alexander Supady, Jenelle Badulak, Laura Evans, J Randall Curtis, Daniel Brodie
276 [GO] 2021―Mar―31 Ethics and evidence: learning lessons from pandemic triage Dominic J C Wilkinson
277 [GO] 2021―Mar―27 European guideline on managing adults in hospital with COVID-19 Priya Venkatesan
278 [GO] 2021―Mar―24 Challenges and opportunities to end tuberculosis in the COVID-19 era Tom Wingfield, Fatima Karmadwala, Peter MacPherson, Kerry A Millington, Naomi F Walker, Luis E Cuevas, S Bertel Squire
279 [GO] 2021―Mar―18 High COVID-19 death rates in prisons in England and Wales, and the need for early vaccination Isobel Braithwaite, Chantal Edge, Dan Lewer, Jake Hard
280 [GO] 2021―Mar―14 Could a good night's sleep improve COVID-19 vaccine efficacy? Christian Benedict, Jonathan Cedernaes
281 [GO] 2021―Mar―07 Desperation in the time of COVID-19 Biplov Adhikari
282 [GO] 2021―Mar―07 COVID-19 and inhaled corticosteroids-another piece in an expanding puzzle Anna Schultze, Ian Douglas
283 [GO] 2021―Mar―07 From female warriors in the rainforest to infectious disease specialists: COVID-19 in the Amazon Izabella Safe
284 [GO] 2021―Mar―07 Challenges in the rollout of COVID-19 vaccines worldwide Talha Khan Burki
285 [GO] 2021―Mar―07 Major differences in ICU admissions during the first and second COVID-19 wave in Germany Christian Karagiannidis, Wolfram Windisch, Daniel F McAuley, Tobias Welte, Reinhard Busse
286 [GO] 2021―Mar―07 Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial Arvinder S Soin, Kuldeep Kumar, Narendra S Choudhary, Pooja Sharma, Yatin Mehta, Sushila Kataria, et al. (+14)
287 [GO] 2021―Mar―07 IL-6 blockade for COVID-19: a global scientific call to arms Srinivas Murthy, Todd C Lee
288 [GO] 2021―Mar―07 Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK Chloe I Bloom, Thomas M Drake, Annemarie B Docherty, Brian J Lipworth, Sebastian L Johnston, Jonathan S Nguyen-Van-Tam, et al. (+337)
289 [GO] 2021―Mar―07 Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial François-Xavier Lescure, Hitoshi Honda, Robert A Fowler, Jennifer Sloane Lazar, Genming Shi, Peter Wung, et al. (+294)
290 [GO] 2021―Mar―07 Young person with long COVID after mild disease Tony Kirby
291 [GO] 2021―Feb―21 Delayed-onset myocarditis following COVID-19 Retesh Bajaj, Hannah C Sinclair, Kush Patel, Ben Low, Ana Pericao, Charlotte Manisty, et al. (+12)
292 [GO] 2021―Feb―16 Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data Annakan V Navaratnam, William K Gray, Jamie Day, Julia Wendon, Tim W R Briggs
293 [GO] 2021―Feb―16 Trends in COVID-19-related in-hospital mortality: lessons learned from nationwide samples Purnema Madahar, Hannah Wunsch, Prabhat Jha, Arthur S Slutsky, Daniel Brodie
294 [GO] 2021―Feb―15 COVID-19 survivor experiencing long-term symptoms Tony Kirby
295 [GO] 2021―Feb―11 COVID-19 in the Caribbean Talha Khan Burki
296 [GO] 2021―Feb―11 Oxygen supplies and COVID-19 mortality in Africa Esther Nakkazi
297 [GO] 2021―Feb―09 Algeria's response to COVID-19: an ongoing journey Selma Nihel Klouche-Djedid, Jaffer Shah, Maya Khodor, Salah Eddine Oussama Kacimi, Sheikh Mohammed Shariful Islam, Hani Aiash
298 [GO] 2021―Feb―07 Provision of holistic care after severe COVID-19 pneumonia Joanne McPeake, Philip Henderson, Pamela MacTavish, Tara Quasim
299 [GO] 2021―Feb―07 Provision of holistic care after severe COVID-19 pneumonia - Authors' reply Rebecca F D'Cruz, Felicity Perrin, Caroline J Jolley, Michael D Waller
300 [GO] 2021―Feb―07 COVID-19 vaccination in athletes: ready, set, go… James H Hull, Martin P Schwellnus, David B Pyne, Anand Shah
301 [GO] 2021―Feb―07 COVID-19: a heavy toll on health-care workers Sangeeta Mehta, Flavia Machado, Arthur Kwizera, Laurent Papazian, Marc Moss, Élie Azoulay, Margaret Herridge
302 [GO] 2021―Feb―07 Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial Jordan J Feld, Christopher Kandel, Mia J Biondi, Robert A Kozak, Muhammad Atif Zahoor, Camille Lemieux, et al. (+29)
303 [GO] 2021―Feb―07 Yemen: Coronavirus in a War Zone Talha Khan Burki
304 [GO] 2021―Jan―30 SARS-CoV-2 evolution and vaccines: cause for concern? Thomas C Williams, Wendy A Burgers
305 [GO] 2021―Jan―28 Living with bronchiectasis during the COVID-19 pandemic Lucy Williamson
306 [GO] 2021―Jan―23 The right place for IL-1 inhibition in COVID-19 Giulio Cavalli, Lorenzo Dagna
307 [GO] 2021―Jan―23 Each person is a world in COVID-19 E Wesley Ely
308 [GO] 2021―Jan―23 Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial Serge Bureau, Maxime Dougados, Annick Tibi, Elie Azoulay, Jacques Cadranel, Joseph Emmerich, et al. (+588)
309 [GO] 2021―Jan―23 Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia Lorenzo Ball, Marcus J Schultz, Paolo Pelosi
310 [GO] 2021―Jan―22 α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action Chengliang Yang, Kenneth R Chapman, Aaron Wong, Mingyao Liu
311 [GO] 2021―Jan―20 Realising the potential of SARS-CoV-2 vaccines-a long shot? The Lancet Respiratory Medicine
312 [GO] 2021―Jan―19 Trial participants' rights after authorisation of COVID-19 vaccines Rafael Dal-Ré, Walter Orenstein, Arthur L Caplan
313 [GO] 2021―Jan―19 An issue of trust-vaccinating Black patients against COVID-19 Dale O Okorodudu, Daniel E Okorodudu
314 [GO] 2021―Jan―19 My COVID-19 dream: training enough health workers Kate Tulenko
315 [GO] 2021―Jan―18 Assessing the importance of interleukin-6 in COVID-19 Luke Y C Chen, Ryan L Hoiland, Sophie Stukas, Cheryl L Wellington, Mypinder S Sekhon
316 [GO] 2021―Jan―18 Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data Otavio T Ranzani, Leonardo S L Bastos, João Gabriel M Gelli, Janaina F Marchesi, Fernanda Baião, Silvio Hamacher, Fernando A Bozza
317 [GO] 2021―Jan―18 Assessing the importance of interleukin-6 in COVID-19 - Authors' reply Daniel E Leisman, Lukas Ronner, Rachel Pinotti, Matthew D Taylor, Pratik Sinha, Carolyn S Calfee, et al. (+6)
318 [GO] 2021―Jan―15 COVID-19: the lessons learned amongst the losses Megan Szekely
319 [GO] 2021―Jan―15 Pandemic thoughts from a British junior doctor in Melbourne Nasreen Moini
320 [GO] 2021―Jan―14 Are women with asthma at increased risk for severe COVID-19? Mario Fernando, Alvar Agusti, Shyamali Dharmage, Caroline Lodge
321 [GO] 2021―Jan―14 Improving clinical management of COVID-19: the role of prediction models Laure Wynants, Giovanni Sotgiu
322 [GO] 2021―Jan―14 Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study Rishi K Gupta, Ewen M Harrison, Antonia Ho, Annemarie B Docherty, Stephen R Knight, Maarten van Smeden, et al. (+369)
323 [GO] 2021―Jan―14 Improving family access to dying patients during the COVID-19 pandemic James Downar, Mike Kekewich
324 [GO] 2021―Jan―14 Implications of COVID-19 sequelae for health-care personnel Nathan Praschan, Sylvia Josephy-Hernandez, David Dongkyung Kim, Michael D Kritzer, Shibani Mukerji, Amy Newhouse, et al. (+2)
325 [GO] 2021―Jan―14 Allocating scarce intensive care resources during the COVID-19 pandemic: practical challenges to theoretical frameworks Alexander Supady, J Randall Curtis, Darryl Abrams, Roberto Lorusso, Thomas Bein, Joachim Boldt, et al. (+4)
326 [GO] 2021―Jan―14 NICE guideline on long COVID Priya Venkatesan
327 [GO] 2021―Jan―12 Sedation in mechanically ventilated patients with COVID-19 Valerie Page
328 [GO] 2021―Jan―12 Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study Brenda T Pun, Rafael Badenes, Gabriel Heras La Calle, Onur M Orun, Wencong Chen, Rameela Raman, et al. (+207)
329 [GO] 2021―Jan―12 A new year, but familiar challenges from COVID-19 in the USA Talha Khan Burki
330 [GO] 2021―Jan―10 Renin-angiotensin system inhibitors in hospitalised patients with COVID-19 Bryan Williams
331 [GO] 2021―Jan―10 New variant of SARS-CoV-2 in UK causes surge of COVID-19 Tony Kirby
332 [GO] 2021―Jan―10 Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial Jordana B Cohen, Thomas C Hanff, Preethi William, Nancy Sweitzer, Nelson R Rosado-Santander, Carola Medina, et al. (+27)
333 [GO] 2020―Dec―18 Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study Lionel Piroth, Jonathan Cottenet, Anne-Sophie Mariet, Philippe Bonniaud, Mathieu Blot, Pascale Tubert-Bitter, Catherine Quantin
334 [GO] 2020―Dec―18 Remdesivir for COVID-19 in Europe: will it provide value for money? Rafael Dal-Ré, Rita Banzi, Sophie Georgin-Lavialle, Raphaël Porcher, Reecha Sofat, Markus Zeitlinger, Frits R Rosendaal
335 [GO] 2020―Dec―18 COVID-19 is not influenza Eskild Petersen
336 [GO] 2020―Dec―11 Could routine race-adjustment of spirometers exacerbate racial disparities in COVID-19 recovery? Meredith A Anderson, Atul Malhotra, Amy L Non
337 [GO] 2020―Dec―01 Successful double-lung transplantation from a donor previously infected with SARS-CoV-2 Laurens J Ceulemans, Jan Van Slambrouck, Paul De Leyn, Herbert Decaluwé, Hans Van Veer, Lieven Depypere, et al. (+17)
338 [GO] 2020―Dec―01 Risks of lung transplantation in the SARS-CoV-2 era Keith C Meyer
339 [GO] 2020―Nov―26 Corticosteroids for COVID-19: the search for an optimum duration of therapy Gyanshankar P Mishra, Jasmin Mulani
340 [GO] 2020―Nov―25 Herd immunity for COVID-19 Talha Khan Burki
341 [GO] 2020―Nov―19 Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19 Ranju T Dhawan, Deepa Gopalan, Luke Howard, Angelito Vicente, Mirae Park, Kavina Manalan, et al. (+7)
342 [GO] 2020―Nov―13 Provision of holistic care after severe COVID-19 pneumonia: anticipating clinical need and managing resources Rebecca F D'Cruz, Felicity Perrin, Surinder S Birring, Amit S Patel, Irem Patel, Caroline J Jolley, Michael D Waller
343 [GO] 2020―Nov―13 Pathophysiology of COVID-19-associated acute respiratory distress syndrome Luigi Camporota, Davide Chiumello, Mattia Busana, Luciano Gattinoni, John J Marini
344 [GO] 2020―Nov―13 Pathophysiology of COVID-19-associated acute respiratory distress syndrome Vasiliki Tsolaki, George E Zakynthinos, Konstantinos Mantzarlis, Vasileios Vazgiourakis, Dimosthenis Makris
345 [GO] 2020―Nov―13 Pathophysiology of COVID-19-associated acute respiratory distress syndrome Michael Dandel
346 [GO] 2020―Nov―13 Pathophysiology of COVID-19-associated acute respiratory distress syndrome Ananthu Narayan, Prerna Garg, Umang Arora, Animesh Ray, Naveet Wig
347 [GO] 2020―Nov―13 Pathophysiology of COVID-19-associated acute respiratory distress syndrome - Authors' reply Giacomo Grasselli, Tommaso Tonetti, Claudia Filippini, Arthur S Slutsky, Antonio Pesenti, V Marco Ranieri
348 [GO] 2020―Nov―12 Nebulised interferon beta-1a for patients with COVID-19 Nathan Peiffer-Smadja, Yazdan Yazdanpanah
349 [GO] 2020―Nov―12 Implementing rapid diagnostics for COVID-19 Camus Nimmo, Joshua Agbetile, Angshu Bhowmik, Santino Capocci, Raj K Rajakulasingam
350 [GO] 2020―Nov―12 Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial Phillip D Monk, Richard J Marsden, Victoria J Tear, Jody Brookes, Toby N Batten, Marcin Mankowski, et al. (+26)
351 [GO] 2020―Oct―30 Overcoming bleeding events related to extracorporeal membrane oxygenation in COVID-19 Hidesaku Asakura, Haruhiko Ogawa
352 [GO] 2020―Oct―30 Overcoming bleeding events related to extracorporeal membrane oxygenation in COVID-19 - Authors' reply Matthieu Schmidt, Juliette Chommeloux, Corinne Frere, Guillaume Hekimian, Alain Combes
353 [GO] 2020―Oct―30 COVID-19 human challenge studies in the UK Tony Kirby
354 [GO] 2020―Oct―30 Juntos en la pandemia de COVID-19 (together in the COVID-19 pandemic): health-care professionals and the Latinx community Sandra E Zaeh, Kathleen R Page, Zackary D Berger, Laura Daly, Katherine Hartman Phillips, Tina Tolson, et al. (+3)
355 [GO] 2020―Oct―30 COVID-19 transmission-up in the air The Lancet Respiratory Medicine
356 [GO] 2020―Oct―30 Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties Michael A Matthay, B Taylor Thompson
357 [GO] 2020―Oct―24 Facemasks as a COVID-19 barrier: a window into the overlooked experience of chronic dyspnoea? Thomas Similowski, Caroline Moricot, Nathalie Nion, Maxens Decavèle, Sophie Lavault, Antoine Guerder, et al. (+2)
358 [GO] 2020―Oct―24 Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study Michela Botta, Anissa M Tsonas, Janesh Pillay, Leonoor S Boers, Anna Geke Algera, Lieuwe D J Bos, et al. (+94)
359 [GO] 2020―Oct―23 Double threat of COVID-19 and influenza Talha Khan Burki
360 [GO] 2020―Oct―23 Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus Stephen Poole, Nathan J Brendish, Alex R Tanner, Tristan W Clark
361 [GO] 2020―Oct―16 Home monitoring for patients with ILD and the COVID-19 pandemic G Nakshbandi, C C Moor, M S Wijsenbeek
362 [GO] 2020―Oct―16 Obstructive sleep apnoea: latest surgical advances and considerations during the COVID-19 pandemic Lucy Williamson
363 [GO] 2020―Oct―16 A call for Essays: stories from the frontline during the COVID-19 pandemic Sophie Woolven
364 [GO] 2020―Oct―16 Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes Daniel E Leisman, Lukas Ronner, Rachel Pinotti, Matthew D Taylor, Pratik Sinha, Carolyn S Calfee, et al. (+6)
365 [GO] 2020―Oct―12 COVID-19 recovery: potential treatments for post-intensive care syndrome Mansoor N Bangash, Andrew Owen, Joseph E Alderman, Minesh Chotalia, Jaimin M Patel, Dhruv Parekh
366 [GO] 2020―Oct―08 Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study Nathan J Brendish, Stephen Poole, Vasanth V Naidu, Christopher T Mansbridge, Nicholas J Norton, Helen Wheeler, et al. (+9)
367 [GO] 2020―Oct―08 Near-patient SARS-CoV-2 molecular platforms: new-old tools for new-old problems Luke S P Moore
368 [GO] 2020―Oct―06 The changing demographics of COVID-19 Priya Venkatesan
369 [GO] 2020―Oct―06 Diagnosis of EVALI in the COVID-19 era Mikhail Kazachkov, Melodi Pirzada
370 [GO] 2020―Oct―01 Completion of clinical trials in light of COVID-19 Talha Khan Burki
371 [GO] 2020―Sep―29 False-positive COVID-19 results: hidden problems and costs Elena Surkova, Vladyslav Nikolayevskyy, Francis Drobniewski
372 [GO] 2020―Sep―25 Human recombinant soluble ACE2 in severe COVID-19 Alexander Zoufaly, Marko Poglitsch, Judith H Aberle, Wolfgang Hoepler, Tamara Seitz, Marianna Traugott, et al. (+14)
373 [GO] 2020―Sep―25 Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying? Dave Singh, David M G Halpin
374 [GO] 2020―Sep―24 COVID-19 among people experiencing homelessness in England: a modelling study Dan Lewer, Isobel Braithwaite, Miriam Bullock, Max T Eyre, Peter J White, Robert W Aldridge, et al. (+2)
375 [GO] 2020―Sep―24 Hard to reach: COVID-19 responses and the complexities of homelessness Mary Flook, Steph Grohmann, Helen R Stagg
376 [GO] 2020―Sep―24 Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform Anna Schultze, Alex J Walker, Brian MacKenna, Caroline E Morton, Krishnan Bhaskaran, Jeremy P Brown, et al. (+26)
377 [GO] 2020―Sep―22 Pooled saliva samples for COVID-19 surveillance programme Andrew Fogarty, Amelia Joseph, Dominick Shaw
378 [GO] 2020―Sep―22 COVID-19 testing in the UK The Lancet Respiratory Medicine
379 [GO] 2020―Sep―21 The UCL Ventura CPAP device for COVID-19 Mervyn Singer, Rebecca Shipley, Tim Baker, Andy Cowell, David Brealey, David Lomas
380 [GO] 2020―Sep―14 Serological assays for delayed SARS-CoV-2 case identification Kay Weng Choy
381 [GO] 2020―Sep―14 Serological assays for delayed SARS-CoV-2 case identification - Author's reply Scott J C Pallett, Michael Rayment, Aatish Patel, Esmita Charani, Sarah J Denny, Sophia A M Fitzgerald-Smith, et al. (+4)
382 [GO] 2020―Sep―06 The Russian vaccine for COVID-19 Talha Khan Burki
383 [GO] 2020―Sep―06 COVID-19 vaccine trials in Africa Munyaradzi Makoni
384 [GO] 2020―Aug―27 Physiological and biological heterogeneity in COVID-19-associated acute respiratory distress syndrome Lorraine B Ware
385 [GO] 2020―Aug―27 Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study Giacomo Grasselli, Tommaso Tonetti, Alessandro Protti, Thomas Langer, Massimo Girardis, Giacomo Bellani, et al. (+32)
386 [GO] 2020―Aug―27 Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study Pratik Sinha, Carolyn S Calfee, Shiney Cherian, David Brealey, Sean Cutler, Charles King, et al. (+12)
387 [GO] 2020―Aug―25 When to consider lung transplantation for COVID-19 Marcelo Cypel, Shaf Keshavjee
388 [GO] 2020―Aug―25 Lung transplantation for COVID-19-associated acute respiratory distress syndrome in a PCR-positive patient Christian Lang, Peter Jaksch, Mir Alireza Hoda, György Lang, Thomas Staudinger, Edda Tschernko, et al. (+16)
389 [GO] 2020―Aug―21 Apples and oranges: international comparisons of COVID-19 observational studies in ICUs Jonathan E Millar, Reinhard Busse, John F Fraser, Christian Karagiannidis, Daniel F McAuley
390 [GO] 2020―Aug―14 The EVALI outbreak and vaping in the COVID-19 era The Lancet Respiratory Medicine
391 [GO] 2020―Aug―13 Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study Matthieu Schmidt, David Hajage, Guillaume Lebreton, Antoine Monsel, Guillaume Voiriot, David Levy, et al. (+54)
392 [GO] 2020―Aug―13 ECMO for severe ARDS associated with COVID-19: now we know we can, but should we? Kiran Shekar, Arthur S Slutsky, Daniel Brodie
393 [GO] 2020―Aug―06 COVID-19, asthma, and return to school Elissa M Abrams, Gráinne McGill, Sunil S Bhopal, Ian Sinha, Ricardo M Fernandes
394 [GO] 2020―Aug―06 SARS-CoV-2 viral load predicts COVID-19 mortality Elisabet Pujadas, Fayzan Chaudhry, Russell McBride, Felix Richter, Shan Zhao, Ania Wajnberg, et al. (+4)
395 [GO] 2020―Aug―04 COVID-19 and preschool wheeze care: lessons learned Heidi Makrinioti, Mando Watson, Andrew Bush, Dougal Hargreaves
396 [GO] 2020―Aug―04 COVID-19 casts light on respiratory health inequalities The Lancet Respiratory Medicine
397 [GO] 2020―Aug―03 How COVID-19 could benefit tuberculosis and HIV services in South Africa Claire Keene, Erika Mohr-Holland, Tali Cassidy, Vera Scott, Aurelie Nelson, Jennifer Furin, Laura Triviño-Duran
398 [GO] 2020―Aug―03 COVID-19 interstitial pneumonia: monitoring the clinical course in survivors Ganesh Raghu, Kevin C Wilson
399 [GO] 2020―Aug―03 Use of facemasks during the COVID-19 pandemic Holger J Schünemann, Elie A Akl, Roger Chou, Derek K Chu, Mark Loeb, Tamara Lotfi, et al. (+5)
400 [GO] 2020―Jul―30 Inhaled corticosteroids in virus pandemics: a treatment for COVID-19? Dan V Nicolau, Mona Bafadhel
401 [GO] 2020―Jul―28 Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study Christian Karagiannidis, Carina Mostert, Corinna Hentschker, Thomas Voshaar, Jürgen Malzahn, Gerhard Schillinger, et al. (+9)
402 [GO] 2020―Jul―28 Mortality in COVID-19 is not merely a question of resource availability Tobias Becher, Inéz Frerichs
403 [GO] 2020―Jul―24 The time to do serosurveys for COVID-19 is now Rosanna W Peeling, Piero L Olliaro
404 [GO] 2020―Jul―24 Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study Scott J C Pallett, Michael Rayment, Aatish Patel, Sophia A M Fitzgerald-Smith, Sarah J Denny, Esmita Charani, et al. (+9)
405 [GO] 2020―Jul―09 Integrated sports and respiratory medicine in the aftermath of COVID-19 Mark A Faghy, Ruth EM Ashton, Tom M Maden-Wilkinson, Robert J Copeland, Thomas Bewick, Andy Smith, Mike Loosemore
406 [GO] 2020―Jul―07 SARS-CoV-2 infection in conjunctival tissue Yu-Chi Liu, Marcus Ang, Hon Shing Ong, Tien Yin Wong, Jodhbir S Mehta
407 [GO] 2020―Jul―07 SARS-CoV-2 infection in conjunctival tissue - Authors' reply Kenrie PY Hui, Malik Peiris, JM Nicholls, Michael CW Chan
408 [GO] 2020―Jul―06 COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Eddy Fan, Jeremy R Beitler, Laurent Brochard, Carolyn S Calfee, Niall D Ferguson, Arthur S Slutsky, Daniel Brodie
409 [GO] 2020―Jun―29 Child poverty, food insecurity, and respiratory health during the COVID-19 pandemic Ian P Sinha, Alice R Lee, Davara Bennett, Louisa McGeehan, Elissa M Abrams, Sarah J Mayell, et al. (+6)
410 [GO] 2020―Jun―26 Identification of pathophysiological patterns for triage and respiratory support in COVID-19 Luigi Camporota, Francesco Vasques, Barnaby Sanderson, Nicholas A Barrett, Luciano Gattinoni
411 [GO] 2020―Jun―25 COVID-19 heralds a new era for chronic diseases in primary care The Lancet Respiratory Medicine
412 [GO] 2020―Jun―25 Asthma in children during the COVID-19 pandemic: lessons from lockdown and future directions for management Atul Gupta, Andrew Bush, Prasad Nagakumar
413 [GO] 2020―Jun―23 Use of aerosolised medications at home for COVID-19 Arzu Ari
414 [GO] 2020―Jun―19 Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study Anna Coppo, Giacomo Bellani, Dario Winterton, Michela Di Pierro, Alessandro Soria, Paola Faverio, et al. (+9)
415 [GO] 2020―Jun―19 Prone positioning in non-intubated patients with COVID-19: raising the bar Laveena Munshi, Michael Fralick, Eddy Fan
416 [GO] 2020―Jun―16 Delivering evidence-based critical care for mechanically ventilated patients with COVID-19 Jorge I F Salluh, Fernando Ramos, Jean Daniel Chiche
417 [GO] 2020―Jun―16 Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities Puja Mehta, Joanna C Porter, Jessica J Manson, John D Isaacs, Peter J M Openshaw, Iain B McInnes, et al. (+2)
418 [GO] 2020―Jun―08 The future of critical care: lessons from the COVID-19 crisis The Lancet Respiratory Medicine
419 [GO] 2020―May―29 Testing for COVID-19 Talha Khan Burki
420 [GO] 2020―May―29 Lung function testing in the COVID-19 endemic James H Hull, Julie K Lloyd, Brendan G Cooper
421 [GO] 2020―May―27 Increased cardiovascular mortality in African Americans with COVID-19 Dennis McGonagle, Sven Plein, James S O'Donnell, Kassem Sharif, Charles Bridgewood
422 [GO] 2020―May―27 Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans Sharon E Fox, Aibek Akmatbekov, Jack L Harbert, Guang Li, J Quincy Brown, Richard S Vander Heide
423 [GO] 2020―May―27 Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission G Aernout Somsen, Cees van Rijn, Stefan Kooij, Reinout A Bem, Daniel Bonn
424 [GO] 2020―May―25 Tobacco smoking and COVID-19 infection Richard N van Zyl-Smit, Guy Richards, Frank T Leone
425 [GO] 2020―May―21 Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19 Alexandre Alanio, Sarah Dellière, Sofiane Fodil, Stéphane Bretagne, Bruno Mégarbane
426 [GO] 2020―May―21 Organoids of human airways to study infectivity and cytopathy of SARS-CoV-2 Mohamed Elbadawi, Thomas Efferth
427 [GO] 2020―May―18 Challenges in the interpretation and application of typical imaging features of COVID-19 Mark M Hammer, Constantine A Raptis, Travis S Henry, Amar Shah, Sanjeev Bhalla, Michael D Hope
428 [GO] 2020―May―18 COVID-19 and the impact of social determinants of health Elissa M Abrams, Stanley J Szefler
429 [GO] 2020―May―18 Delayed diagnosis of COVID-19 in a 34-year-old man with atypical presentation Timothy J Harkin, Kevin M Rurak, John Martins, Corey Eber, Arnold H Szporn, Mary Beth Beasley
430 [GO] 2020―May―16 Walking the line between benefit and harm from tracheostomy in COVID-19 Marcus J Schultz, Rajyabardhan Pattnaik, Arjen M Dondorp
431 [GO] 2020―May―16 Tracheostomy in the COVID-19 era: global and multidisciplinary guidance Brendan A McGrath, Michael J Brenner, Stephen J Warrillow, Vinciya Pandian, Asit Arora, Tanis S Cameron, et al. (+24)
432 [GO] 2020―May―16 Pulmonary fibrosis secondary to COVID-19: a call to arms? Paolo Spagnolo, Elisabetta Balestro, Stefano Aliberti, Elisabetta Cocconcelli, Davide Biondini, Giovanni Della Casa, et al. (+2)
433 [GO] 2020―May―16 Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy Peter M George, Athol U Wells, R Gisli Jenkins
434 [GO] 2020―May―15 Management of acute kidney injury in patients with COVID-19 Claudio Ronco, Thiago Reis, Faeq Husain-Syed
435 [GO] 2020―May―13 SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors Stephen Milne, Chen Xi Yang, Wim Timens, Yohan Bossé, Don D Sin
436 [GO] 2020―May―10 Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities Tony Kirby
437 [GO] 2020―May―07 Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures Kenrie P Y Hui, Man-Chun Cheung, Ranawaka A P M Perera, Ka-Chun Ng, Christine H T Bui, John C W Ho, et al. (+8)
438 [GO] 2020―May―07 Assessment of SARS-CoV-2 replication in the context of other respiratory viruses Jessica A Belser
439 [GO] 2020―May―05 Airway management for COVID-19: a move towards universal videolaryngoscope? Audrey De Jong, Emmanuel Pardo, Amélie Rolle, Sandra Bodin-Lario, Yvan Pouzeratte, Samir Jaber
440 [GO] 2020―May―04 A 5-point strategy for improved connection with relatives of critically ill patients with COVID-19 Elie Azoulay, Nancy Kentish-Barnes
441 [GO] 2020―May―04 Immunomodulation in COVID-19 Nicholas E Ingraham, Sahar Lotfi-Emran, Beth K Thielen, Kristina Techar, Rachel S Morris, Shernan G Holtan, et al. (+2)
442 [GO] 2020―Apr―29 South America prepares for the impact of COVID-19 Tony Kirby
443 [GO] 2020―Apr―29 Keeping COVID-19 at bay in Africa Munyaradzi Makoni
444 [GO] 2020―Apr―29 COVID-19 in Nigeria: a disease of hunger Bernard Kalu
445 [GO] 2020―Apr―28 Considerations for ventilator triage during the COVID-19 pandemic Max M Feinstein, Joshua D Niforatos, Insoo Hyun, Thomas V Cunningham, Alexandra Reynolds, Daniel Brodie, Adam Levine
446 [GO] 2020―Apr―28 Immunotherapies for COVID-19: lessons learned from sepsis Kenneth E Remy, Scott C Brakenridge, Bruno Francois, Thomas Daix, Clifford S Deutschman, Guillaume Monneret, et al. (+4)
447 [GO] 2020―Apr―27 COVID-19 cytokine storm: the interplay between inflammation and coagulation Ricardo J Jose, Ari Manuel
448 [GO] 2020―Apr―23 Reflecting on World Asthma Day in the era of COVID-19 The Lancet Respiratory Medicine
449 [GO] 2020―Apr―22 Screening and triage at health-care facilities in Timor-Leste during the COVID-19 pandemic Rosemary Howitt, Gustodio Alves de Jesus, Flavio Araujo, Joshua Francis, Ian Marr, Melanie McVean, et al. (+4)
450 [GO] 2020―Apr―21 High versus low PEEP in non-recruitable collapsed lung tissue: possible implications for patients with COVID-19 Marcus J Schultz
451 [GO] 2020―Apr―21 Use of non-invasive ventilation for patients with COVID-19: a cause for concern? Nishkantha Arulkumaran, David Brealey, David Howell, Mervyn Singer
452 [GO] 2020―Apr―16 Kidney transplant programmes during the COVID-19 pandemic Francesca Martino, Mario Plebani, Claudio Ronco
453 [GO] 2020―Apr―16 Blood transfusion strategies and ECMO during the COVID-19 pandemic David Koeckerling, Daniel Pan, N Lakmal Mudalige, Oluwatobiloba Oyefeso, Joseph Barker
454 [GO] 2020―Apr―16 Blood transfusion strategies and ECMO during the COVID-19 pandemic - Authors' reply Kollengode Ramanathan, Graeme MacLaren, Alain Combes, Daniel Brodie, Kiran Shekar
455 [GO] 2020―Apr―15 Impact of COVID-19 on people with cystic fibrosis Carla Colombo, Pierre-Régis Burgel, Silvia Gartner, Silke van Koningsbruggen-Rietschel, Lutz Naehrlich, Isabelle Sermet-Gaudelus, Kevin W Southern
456 [GO] 2020―Apr―15 Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base Fabio S Taccone, Julie Gorham, Jean-Louis Vincent
457 [GO] 2020―Apr―09 Challenges in lung cancer therapy during the COVID-19 pandemic Luana Calabrò, Solange Peters, Jean-Charles Soria, Anna Maria Di Giacomo, Fabrice Barlesi, Alessia Covre, et al. (+6)
458 [GO] 2020―Apr―09 COVID-19: Respiratory support outside the intensive care unit Tom McEnery, Ciara Gough, Richard W Costello
459 [GO] 2020―Apr―08 Respiratory health in athletes: facing the COVID-19 challenge James H Hull, Mike Loosemore, Martin Schwellnus
460 [GO] 2020―Apr―08 POCUS in COVID-19: pearls and pitfalls Jonathan Chun-Hei Cheung, Koon Ngai Lam
461 [GO] 2020―Apr―06 Understanding pathways to death in patients with COVID-19 Jean-Louis Vincent, Fabio S Taccone
462 [GO] 2020―Apr―06 Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations Jason Phua, Li Weng, Lowell Ling, Moritoki Egi, Chae-Man Lim, Jigeeshu Vasishtha Divatia, et al. (+7)
463 [GO] 2020―Apr―04 Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? David M G Halpin, Rosa Faner, Oriol Sibila, Joan Ramon Badia, Alvar Agusti
464 [GO] 2020―Apr―02 Monitoring the COVID-19 epidemic in the context of widespread local transmission Alberto L García-Basteiro, Carlos Chaccour, Caterina Guinovart, Anna Llupià, Joe Brew, Antoni Trilla, Antoni Plasencia
465 [GO] 2020―Apr―01 UK senior police officer with COVID-19 Tony Kirby
466 [GO] 2020―Mar―27 COVID-19 infection in children Ian P Sinha, Rachel Harwood, Malcolm G Semple, Daniel B Hawcutt, Rebecca Thursfield, Omendra Narayan, et al. (+4)
467 [GO] 2020―Mar―26 Efforts escalate to protect homeless people from COVID-19 in UK Tony Kirby
468 [GO] 2020―Mar―26 Antihypertensive drugs and risk of COVID-19? Christopher J Tignanelli, Nicholas E Ingraham, Matthew A Sparks, Ronald Reilkoff, Tamara Bezdicek, Bradley Benson, et al. (+3)
469 [GO] 2020―Mar―26 Antihypertensive drugs and risk of COVID-19? Joshua D Brown
470 [GO] 2020―Mar―26 Antihypertensive drugs and risk of COVID-19? Kevin Bryan Lo, Peter A McCullough, Janani Rangaswami
471 [GO] 2020―Mar―26 Antihypertensive drugs and risk of COVID-19? - Authors' reply Lei Fang, George Karakiulakis, Michael Roth
472 [GO] 2020―Mar―25 The role of CT in case ascertainment and management of COVID-19 pneumonia in the UK: insights from high-incidence regions Felix Chua, Darius Armstrong-James, Sujal R Desai, Joseph Barnett, Vasileios Kouranos, Onn Min Kon, et al. (+20)
473 [GO] 2020―Mar―24 Tackling two pandemics: a plea on World Tuberculosis Day Tom Wingfield, Luis E Cuevas, Peter MacPherson, Kerry A Millington, S Bertel Squire
474 [GO] 2020―Mar―20 Treatment for severe acute respiratory distress syndrome from COVID-19 Michael A Matthay, J Matthew Aldrich, Jeffrey E Gotts
475 [GO] 2020―Mar―20 COVID-19 outbreak: less stethoscope, more ultrasound Danilo Buonsenso, Davide Pata, Antonio Chiaretti
476 [GO] 2020―Mar―20 Rational use of face masks in the COVID-19 pandemic Shuo Feng, Chen Shen, Nan Xia, Wei Song, Mengzhen Fan, Benjamin J Cowling
477 [GO] 2020―Mar―20 Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases Kollengode Ramanathan, David Antognini, Alain Combes, Matthew Paden, Bishoy Zakhary, Mark Ogino, et al. (+3)
478 [GO] 2020―Mar―17 COVID-19: the need for continuous medical education and training Li Li, Qianghong Xv, Jing Yan
479 [GO] 2020―Mar―16 COVID-19: delay, mitigate, and communicate The Lancet Respiratory Medicine
480 [GO] 2020―Mar―13 COVID-19, ECMO, and lymphopenia: a word of caution Brandon Michael Henry
481 [GO] 2020―Mar―12 Sex difference and smoking predisposition in patients with COVID-19 Hua Cai
482 [GO] 2020―Mar―12 Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lei Fang, George Karakiulakis, Michael Roth
483 [GO] 2020―Mar―12 Adoption of COVID-19 triage strategies for low-income settings Rodgers R Ayebare, Robert Flick, Solome Okware, Bongomin Bodo, Mohammed Lamorde
484 [GO] 2020―Mar―05 Respiratory support for patients with COVID-19 infection Silvio A Ñamendys-Silva
485 [GO] 2020―Feb―25 Staff safety during emergency airway management for COVID-19 in Hong Kong Jonathan Chun-Hei Cheung, Lap Tin Ho, Justin Vincent Cheng, Esther Yin Kwan Cham, Koon Ngai Lam
486 [GO] 2020―Feb―24 Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Xiaobo Yang, Yuan Yu, Jiqian Xu, Huaqing Shu, Jia'an Xia, Hong Liu, et al. (+10)
487 [GO] 2020―Feb―21 Pandemic: examining readiness for infectious disease outbreaks Talha Khan Burki
488 [GO] 2020―Feb―18 Pathological findings of COVID-19 associated with acute respiratory distress syndrome Zhe Xu, Lei Shi, Yijin Wang, Jiyuan Zhang, Lei Huang, Chao Zhang, et al. (+12)
489 [GO] 2020―Feb―13 Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics Jinnong Zhang, Luqian Zhou, Yuqiong Yang, Wei Peng, Wenjing Wang, Xuelin Chen
490 [GO] 2020―Feb―13 Protecting health-care workers from subclinical coronavirus infection De Chang, Huiwen Xu, Andre Rebaza, Lokesh Sharma, Charles S Dela Cruz
491 [GO] 2020―Feb―13 Toning down the 2019-nCoV media hype-and restoring hope Giuseppe Ippolito, David S Hui, Francine Ntoumi, Markus Maeurer, Alimuddin Zumla
492 [GO] 2020―Feb―07 Australian Government releases face masks to protect against coronavirus Tony Kirby
493 [GO] 2020―Feb―06 Coronavirus epidemic: preparing for extracorporeal organ support in intensive care Claudio Ronco, Paolo Navalesi, Jean Louis Vincent
494 [GO] 2020―Feb―03 Coronavirus in China Talha Khan Burki
495 [GO] 2019―Dec―16 Planning for the next pandemic: a call for new guidance Joe Brierley, Stephen Playfor, Samiran Ray

495 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.140 sec